Records containing: Hypertension, Pulmonary
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-10-08A Randomized, Open Label Study Comparing Safety and Efficacy Parameters for a High and a Low Dose of Ambrisentan (Adjusted for Body Weight) for the Treatment of Pulmonary Arterial Hypertension in Paediatric Patients Aged 8 Years up to 18 Years
-
CLINICAL_TRIALS study record update · 2019-08-13Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2019-07-05Effect of Sildenafil for the Treatment of Sustained Pulmonary Artery Hypertension After Corrected Mitral Valve Disease
-
CLINICAL_TRIALS study record update · 2019-06-19EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2019-04-02Qualitative Research to Explore Patient Preference for Modes of Administration in Pulmonary Arterial Hypertension Treatments
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-03-26Prospective Multicentre Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2019-02-21An Open-label, International, Multicenter, Single-arm, Uncontrolled, Phase IIIb Study of Riociguat in Patients With Pulmonary Arterial Hypertension (PAH) Who Demonstrate an Insufficient Response to Treatment With Phosphodiesterase-5 Inhibitors (PDE-5i)
-
CLINICAL_TRIALS study record update · 2019-01-22A Phase 1 Study to Demonstrate the Relative Bioavailability of Fixed Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2018-08-17A Microdose Study to Evaluate the Biodistribution of [11C]-GSK2256098 in the Lungs and Heart of Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients Using Positron Emission Tomography (PET)
-
CLINICAL_TRIALS study record update · 2018-07-11The Exercise Capacity and Quality of Life in the Patients With Idiopathic Pulmonary Arterial Hypertension and Secondary Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2018-07-09Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
-
CLINICAL_TRIALS study record update · 2018-06-12First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension: A Safety and Efficacy Pilot Study
-
CLINICAL_TRIALS study record update · 2018-04-09The Evaluation and Treatment of Elevated Left-Sided Filling Pressures by Balloon Inflation Within the Interior Vena Cava
-
CLINICAL_TRIALS study record update · 2017-12-20(e-MOTION PH) Electronic - Activity Level Monitoring Pilot in Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2017-12-07A Multi-center, Non-randomized, Open Label, Single-arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of BAY q 6256 (Iloprost) Inhalation in Patients With Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2017-10-24A Phase 2a, Randomized, Double Blind, Placebo-controlled, Parallel Group Study Investigating The Dose-response Of Pf-00489791 On Acute Hemodynamics In Subjects With Idiopathic And Familial Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2017-10-16A Single-arm, Open Label Study Evaluating the Impact on Lifestyle of a New Thermo Stable Formulation of FLOLAN® in Subjects With Pulmonary Arterial Hypertension (PAH). (FLOLAN® is a Registered Trademark of the GlaxoSmithKline Group of Companies.)
-
CLINICAL_TRIALS study record update · 2017-10-13A Phase IV, Prospective, Single-Arm, Open-Label Study to Measure Outcomes in Patients With Pulmonary Arterial Hypertension Not on Active Treatment
-
CLINICAL_TRIALS study record update · 2017-09-26Early Inhaled Nitric Oxide Therapy in Term and Near Term Infants With Respiratory Failure
-
CLINICAL_TRIALS study record update · 2017-09-26The Randomized Inhaled Nitric Oxide Study (NINOS) in Full-Term and Nearly Full-Term Infants With Hypoxic Respiratory Failure
-
CLINICAL_TRIALS study record update · 2017-09-26Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
-
CLINICAL_TRIALS study record update · 2017-07-21A Clinical Trial of Aspirin and Simvastatin in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2017-06-09Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2017-06-02CombinatiON Up-FRON t Therapy for PAH - A Phase 4, Randomized, Multicenter Study of Inhaled Treprostinil in Treatment naïve Pulmonary Arterial Hypertension Patients Starting on Tadalafil
-
CLINICAL_TRIALS study record update · 2017-05-24Retrospective Chart Review of Patients With PAH or Inoperable/Persistent/Recurrent CTEPH Who Transition Their PH Treatment to Adempas